Thiogenesis Receives Final EU Clearance of CTA to Initiate its Phase 2 Clinical Trial in MELAS
Thiogenesis Therapeutics, and Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing disulfides that drive the production of critically important ...
bovnews10d
Tetra Technologies Inc (TTI) Stock Price Reaches $4.98: What Factors Are Influencing This Level?
Tetra Technologies Inc (TTI) stock saw a modest uptick, ending the day at $4.98 which represents a slight increase of $0.27 or 5.73% from the prior close of $4.71. The stock opened at $4.71 and ...
bovnews12d
Tetra Technologies Inc (TTI) Posted 0.27% Profit Margin Last Year—Can It Hold Up?
The Benchmark Company has recently initiated Tetra Technologies Inc (TTI) stock to Buy rating, as announced on September 28, 2023, according to Finviz. Earlier, on June 24, 2022, Johnson Rice had ...